The kynurenine pathway of tryptophan metabolism is currently of consid
erable interest due to biological activities of various kynurenine met
abolites. The most important appears to be quinolinic acid, which has
been implicated as an etiological factor in a range of neurodegenerati
ve diseases. The enzymes on the pathway are also mechanistically inter
esting and have some unusual features. This review describes the pathw
ay, discusses the mechanisms of the enzymes involved and examines the
strategies that have been employed for inhibitor design.